[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$nktr
Nektar Therapeutics (NKTR) sees significant social media buzz around potential acquisition by Eli Lilly, alongside positive clinical trial updates. However, ongoing legal battles and market volatility introduce critical concerns for investors.
About $nktr
Nektar Therapeutics is a biotechnology company focused on developing innovative therapies.
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXXX +2.50%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXXX +830%
X Year: XXXXXXXXXX +1,884%
1-Year High: XXXXXXXXX on 2025-06-24
1-Year Low: XX on 2024-12-19
Engagements by network (24h): X: XXXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXXX +3,627%
X Year: XXXXXX +2,628%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2025-02-03
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $nktr in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXXX +3,713%
X Year: XXXXXX +3,489%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2025-02-01
The most influential creators that mention $nktr in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXXXX |
| @PersimmonTI | X | XXXXXX | X | XXX |
| @seedy19tron | X | XXXXX | X | XXX |
| @doepke_michel | X | XXXXX | X | XXX |
| @HeikwanTrades | X | XXX | X | XXX |
| @kingkang80 | X | XXX | X | XXX |
| @Banana_Oncology | X | XXXXX | X | XXX |
| @slay_ad | X | XXX | X | XX |
| @Tickeron | X | XXXXXX | X | XX |
| @WOLF_Financial | XX | XXXXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% -X%
X Months: XX% +17%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-11
1-Year Low: XX% on 2025-03-31
Most Supportive Themes:
- Acquisition Rumors: (60%) Speculation surrounding a potential acquisition by Eli Lilly is driving significant interest and positive sentiment.
- Clinical Trial Data & Designations: (20%) Positive clinical trial data, including the FDA's Fast Track designation for Rezpegaldesleukin, is boosting confidence in the company's pipeline.
Most Critical Themes:
- Legal Proceedings & Market Volatility: (20%) Concerns persist regarding ongoing legal battles and general market fluctuations impacting the stock's stability.
Top $nktr Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$OCUL Stock: Ocular Therapeutix (OCUL $16.11) was a top quarterly gainer rising +26.25% $BCRX $ADPT $SRPT $NVAX $NKTR"
X Link @Tickeron 2025-12-10T04:30Z 19.3K followers, XXX engagements
"$xbi $rzlt $xoma $rare $rytm $amlx $zeal $abvx $nktr $gpcr $wve $tern"
X Link @tra53795 2025-12-09T18:43Z XX followers, XXX engagements
"@ACapitalLP $ABVX buyout spec $MREO p3 data drop within the next X weeks $NKTR imminent data + LLY settlement $ pending $PZZA buyout spec $ZIM buyout spec"
X Link @CypherdC 2025-12-09T16:09Z XXX followers, 3173 engagements
"$NKTR.Just a reminder.we are X days away from the pre-trial conference update in San Francisco.December 11th at 11AM between $NKTR and $LLY. Thoughts"
X Link @AdvisorsEdge 2025-12-09T14:17Z XXX followers, 9400 engagements